Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Villagra

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 4, 2011
Histone deacetylase inhibitor LAQ824 augments inflammatory responses in macrophages through transcriptional regulation of IL-10Hongwei Wang, Fengdong Cheng, Karrune Woan, et al.
Nature Immunology|January 29, 2013
Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancerJe-In Youn, Vinit Kumar, Michelle Collazo, et al.
Nature Immunology|November 18, 2008
The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune toleranceAlejandro Villagra, Fengdong Cheng, Hong-Wei Wang, et al.
Molecular Immunology|April 22, 2014
Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cellsFengdong Cheng, Maritza Lienlaf, Patricio Perez-Villarroel, et al.
Scientific Reports|February 28, 2020
Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancerSara Moufarrij, Aneil Srivastava, Stephanie Gomez, et al.
Cancer Research|July 2, 2020
HDAC6 Plays a Noncanonical Role in the Regulation of Antitumor Immune Responses, Dissemination, and Invasiveness of Breast CancerDebarati Banik, Satish Noonepalle, Melissa Hadley, et al.
Molecular and Cellular Biology|April 17, 2003
Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activityJose Sierra, Alejandro Villagra, Roberto Paredes, et al.
Bone Marrow Transplantation|April 20, 2018
Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host diseaseLia Perez, Hugo Fernandez, Pedro Horna, et al.
Scientific Reports|October 11, 2019
Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cellsTessa Knox, Eva Sahakian, Debarati Banik, et al.
Scientific Reports|April 18, 2019
Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cellsTessa Knox, Eva Sahakian, Debarati Banik, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|March 4, 2011
Histone deacetylase inhibitor LAQ824 augments inflammatory responses in macrophages through transcriptional regulation of IL-10Hongwei Wang, Fengdong Cheng, Karrune Woan, et al.
Nature Immunology|January 29, 2013
Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancerJe-In Youn, Vinit Kumar, Michelle Collazo, et al.
Nature Immunology|November 18, 2008
The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune toleranceAlejandro Villagra, Fengdong Cheng, Hong-Wei Wang, et al.
Molecular Immunology|April 22, 2014
Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cellsFengdong Cheng, Maritza Lienlaf, Patricio Perez-Villarroel, et al.
Scientific Reports|February 28, 2020
Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancerSara Moufarrij, Aneil Srivastava, Stephanie Gomez, et al.
Cancer Research|July 2, 2020
HDAC6 Plays a Noncanonical Role in the Regulation of Antitumor Immune Responses, Dissemination, and Invasiveness of Breast CancerDebarati Banik, Satish Noonepalle, Melissa Hadley, et al.
Molecular and Cellular Biology|April 17, 2003
Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activityJose Sierra, Alejandro Villagra, Roberto Paredes, et al.
Bone Marrow Transplantation|April 20, 2018
Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host diseaseLia Perez, Hugo Fernandez, Pedro Horna, et al.
Scientific Reports|October 11, 2019
Author Correction: Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cellsTessa Knox, Eva Sahakian, Debarati Banik, et al.
Scientific Reports|April 18, 2019
Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cellsTessa Knox, Eva Sahakian, Debarati Banik, et al.
Pageof 6